pentobarbital will decrease the level or effect of mavacamten by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.pentobarbital will minimize the level or influence of oliceridine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. If coadministration which has a CYP3A4 inducer is critical, co… Read More